位置:首页 > 蛋白库 > PREP_MOUSE
PREP_MOUSE
ID   PREP_MOUSE              Reviewed;        1036 AA.
AC   Q8K411; Q3THC4; Q3TJI1; Q3TPP0; Q3URQ8; Q4KUG2; Q4KUG3; Q6ZPX6; Q922N1;
AC   Q9CV63;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   03-AUG-2022, entry version 135.
DE   RecName: Full=Presequence protease, mitochondrial {ECO:0000305};
DE            EC=3.4.24.- {ECO:0000250|UniProtKB:Q5JRX3};
DE   AltName: Full=Pitrilysin metalloproteinase 1 {ECO:0000250|UniProtKB:Q5JRX3};
DE   Flags: Precursor;
GN   Name=Pitrm1 {ECO:0000312|MGI:MGI:1916867};
GN   Synonyms=Kiaa1104 {ECO:0000312|EMBL:BAC98102.1},
GN   Ntup1 {ECO:0000312|EMBL:AAM49783.1};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INDUCTION.
RC   STRAIN=C57BL/6J;
RX   PubMed=12490196; DOI=10.1006/dbio.2002.0870;
RA   Suemizu H., Aiba K., Yoshikawa T., Sharov A.A., Shimozawa N., Tamaoki N.,
RA   Ko M.S.H.;
RT   "Expression profiling of placentomegaly associated with nuclear
RT   transplantation of mouse ES cells.";
RL   Dev. Biol. 253:36-53(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS GLN-15; ILE-17;
RP   CYS-19; MET-462; LYS-546 AND VAL-583.
RC   STRAIN=LG/J, and SM/J;
RX   PubMed=15919810; DOI=10.2337/diabetes.54.6.1863;
RA   Ehrich T.H., Hrbek T., Kenney-Hunt J.P., Pletscher L.S., Wang B.,
RA   Semenkovich C.F., Cheverud J.M.;
RT   "Fine-mapping gene-by-diet interactions on chromosome 13 in a LG/J x SM/J
RT   murine model of obesity.";
RL   Diabetes 54:1863-1872(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   STRAIN=BALB/cJ, and C57BL/6J; TISSUE=Amnion, and Tongue;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-1036 (ISOFORM 1).
RC   TISSUE=Embryonic tail;
RX   PubMed=14621295; DOI=10.1093/dnares/10.4.167;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: III.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 10:167-180(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 395-1036.
RC   STRAIN=FVB/N; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-759, SUCCINYLATION [LARGE SCALE
RP   ANALYSIS] AT LYS-770; LYS-848 AND LYS-945, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast, and Liver;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-770 AND LYS-883, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=23576753; DOI=10.1073/pnas.1302961110;
RA   Rardin M.J., Newman J.C., Held J.M., Cusack M.P., Sorensen D.J., Li B.,
RA   Schilling B., Mooney S.D., Kahn C.R., Verdin E., Gibson B.W.;
RT   "Label-free quantitative proteomics of the lysine acetylome in mitochondria
RT   identifies substrates of SIRT3 in metabolic pathways.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:6601-6606(2013).
CC   -!- FUNCTION: Metalloendopeptidase of the mitochondrial matrix that
CC       functions in peptide cleavage and degradation rather than in protein
CC       processing. Has an ATP-independent activity. Specifically cleaves
CC       peptides in the range of 5 to 65 residues. Shows a preference for
CC       cleavage after small polar residues and before basic residues, but
CC       without any positional preference. Degrades the transit peptides of
CC       mitochondrial proteins after their cleavage. Also degrades other
CC       unstructured peptides. It is also able to degrade amyloid-beta protein
CC       40, one of the peptides produced by APP processing, when it accumulates
CC       in mitochondrion. It is a highly efficient protease, at least toward
CC       amyloid-beta protein 40. Cleaves that peptide at a specific position
CC       and is probably not processive, releasing digested peptides
CC       intermediates that can be further cleaved subsequently. It is also able
CC       to degrade amyloid-beta protein 42. {ECO:0000250|UniProtKB:Q5JRX3}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:Q5JRX3};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:Q5JRX3};
CC   -!- ACTIVITY REGULATION: Mainly exists in a closed and catalytically
CC       competent conformation but a closed-to-open switch allows substrate
CC       entry into the catalytic chamber. Substrate binding induces closure and
CC       dimerization. A disulfide bond may lock the enzyme in a closed
CC       conformation preventing substrate entry into the catalytic chamber,
CC       participating in redox regulation of the enzyme. Inhibited by metal-
CC       chelating agents. Inhibited by nickel and zinc excess, and slightly
CC       activated by manganese. {ECO:0000250|UniProtKB:Q5JRX3}.
CC   -!- SUBUNIT: Monomer and homodimer; homodimerization is induced by binding
CC       of the substrate. {ECO:0000250|UniProtKB:Q5JRX3}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000250|UniProtKB:Q5JRX3}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8K411-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8K411-2; Sequence=VSP_020598;
CC       Name=3;
CC         IsoId=Q8K411-3; Sequence=VSP_020598, VSP_020599;
CC   -!- INDUCTION: Up-regulated transplantes nuclei derived from embryonic stem
CC       (ES) cells. {ECO:0000269|PubMed:12490196}.
CC   -!- PTM: A disulfide bond locks the enzyme in the closed conformation
CC       preventing substrate entry into the catalytic chamber.
CC       {ECO:0000250|UniProtKB:Q5JRX3}.
CC   -!- SIMILARITY: Belongs to the peptidase M16 family. PreP subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH06917.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF513714; AAM49783.1; -; mRNA.
DR   EMBL; AY779273; AAX11355.1; -; mRNA.
DR   EMBL; AY779274; AAX11356.1; -; mRNA.
DR   EMBL; AK009313; BAB26211.1; -; mRNA.
DR   EMBL; AK141277; BAE24630.1; -; mRNA.
DR   EMBL; AK147837; BAE28172.1; -; mRNA.
DR   EMBL; AK164235; BAE37695.1; -; mRNA.
DR   EMBL; AK167426; BAE39514.1; -; mRNA.
DR   EMBL; AK168335; BAE40273.1; -; mRNA.
DR   EMBL; AK129292; BAC98102.1; -; mRNA.
DR   EMBL; BC006917; AAH06917.1; ALT_INIT; mRNA.
DR   CCDS; CCDS36585.1; -. [Q8K411-1]
DR   RefSeq; NP_660113.1; NM_145131.1. [Q8K411-1]
DR   RefSeq; XP_006516571.1; XM_006516508.1.
DR   AlphaFoldDB; Q8K411; -.
DR   SMR; Q8K411; -.
DR   BioGRID; 213572; 6.
DR   STRING; 10090.ENSMUSP00000021611; -.
DR   iPTMnet; Q8K411; -.
DR   PhosphoSitePlus; Q8K411; -.
DR   SwissPalm; Q8K411; -.
DR   EPD; Q8K411; -.
DR   jPOST; Q8K411; -.
DR   MaxQB; Q8K411; -.
DR   PaxDb; Q8K411; -.
DR   PeptideAtlas; Q8K411; -.
DR   PRIDE; Q8K411; -.
DR   ProteomicsDB; 289402; -. [Q8K411-1]
DR   ProteomicsDB; 289403; -. [Q8K411-2]
DR   ProteomicsDB; 289404; -. [Q8K411-3]
DR   Antibodypedia; 1721; 191 antibodies from 30 providers.
DR   DNASU; 69617; -.
DR   Ensembl; ENSMUST00000021611; ENSMUSP00000021611; ENSMUSG00000021193. [Q8K411-3]
DR   Ensembl; ENSMUST00000222485; ENSMUSP00000152229; ENSMUSG00000021193. [Q8K411-1]
DR   GeneID; 69617; -.
DR   KEGG; mmu:69617; -.
DR   UCSC; uc007pjx.1; mouse. [Q8K411-1]
DR   UCSC; uc007pjy.1; mouse. [Q8K411-2]
DR   UCSC; uc011ywa.1; mouse. [Q8K411-3]
DR   CTD; 10531; -.
DR   MGI; MGI:1916867; Pitrm1.
DR   VEuPathDB; HostDB:ENSMUSG00000021193; -.
DR   eggNOG; KOG2019; Eukaryota.
DR   GeneTree; ENSGT00390000018381; -.
DR   HOGENOM; CLU_009165_0_0_1; -.
DR   InParanoid; Q8K411; -.
DR   OMA; MTYPDKT; -.
DR   OrthoDB; 107079at2759; -.
DR   PhylomeDB; Q8K411; -.
DR   TreeFam; TF300333; -.
DR   BRENDA; 3.4.24.56; 3474.
DR   Reactome; R-MMU-1268020; Mitochondrial protein import.
DR   BioGRID-ORCS; 69617; 15 hits in 73 CRISPR screens.
DR   ChiTaRS; Pitrm1; mouse.
DR   PRO; PR:Q8K411; -.
DR   Proteomes; UP000000589; Chromosome 13.
DR   RNAct; Q8K411; protein.
DR   Bgee; ENSMUSG00000021193; Expressed in embryonic post-anal tail and 291 other tissues.
DR   ExpressionAtlas; Q8K411; baseline and differential.
DR   Genevisible; Q8K411; MM.
DR   GO; GO:0005759; C:mitochondrial matrix; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; HDA:MGI.
DR   GO; GO:0004222; F:metalloendopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0008237; F:metallopeptidase activity; ISO:MGI.
DR   GO; GO:0008270; F:zinc ion binding; ISO:MGI.
DR   GO; GO:0016485; P:protein processing; IBA:GO_Central.
DR   GO; GO:0006508; P:proteolysis; ISS:UniProtKB.
DR   InterPro; IPR011249; Metalloenz_LuxS/M16.
DR   InterPro; IPR011765; Pept_M16_N.
DR   InterPro; IPR007863; Peptidase_M16_C.
DR   InterPro; IPR013578; Peptidase_M16C_assoc.
DR   Pfam; PF08367; M16C_assoc; 1.
DR   Pfam; PF00675; Peptidase_M16; 1.
DR   Pfam; PF05193; Peptidase_M16_C; 2.
DR   SMART; SM01264; M16C_associated; 1.
DR   SUPFAM; SSF63411; SSF63411; 4.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Disulfide bond; Hydrolase;
KW   Metal-binding; Metalloprotease; Mitochondrion; Protease;
KW   Reference proteome; Transit peptide; Zinc.
FT   TRANSIT         1..15
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000250"
FT   CHAIN           16..1036
FT                   /note="Presequence protease, mitochondrial"
FT                   /id="PRO_0000249932"
FT   REGION          806..833
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        107
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q5JRX3"
FT   BINDING         104
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q5JRX3"
FT   BINDING         108
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q5JRX3"
FT   BINDING         205
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q5JRX3"
FT   MOD_RES         759
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         770
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:23576753"
FT   MOD_RES         770
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         848
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         883
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23576753"
FT   MOD_RES         945
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   DISULFID        119..556
FT                   /evidence="ECO:0000250|UniProtKB:Q5JRX3"
FT   VAR_SEQ         20
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_020598"
FT   VAR_SEQ         380..417
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_020599"
FT   VARIANT         15
FT                   /note="R -> Q (in strain: LG/J and SM/J)"
FT                   /evidence="ECO:0000269|PubMed:15919810"
FT   VARIANT         17
FT                   /note="S -> I (in strain: LG/J and SM/J)"
FT                   /evidence="ECO:0000269|PubMed:15919810"
FT   VARIANT         19
FT                   /note="G -> C (in strain: LG/J and SM/J)"
FT                   /evidence="ECO:0000269|PubMed:15919810"
FT   VARIANT         462
FT                   /note="V -> M (in strain: LG/J and SM/J)"
FT                   /evidence="ECO:0000269|PubMed:15919810"
FT   VARIANT         546
FT                   /note="T -> K (in strain: LG/J and SM/J)"
FT                   /evidence="ECO:0000269|PubMed:15919810"
FT   VARIANT         583
FT                   /note="I -> V (in strain: LG/J and SM/J)"
FT                   /evidence="ECO:0000269|PubMed:15919810"
FT   CONFLICT        7
FT                   /note="R -> G (in Ref. 3; BAE37695)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        283
FT                   /note="E -> D (in Ref. 3; BAE39514)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        388
FT                   /note="Y -> C (in Ref. 3; BAE24630)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        394
FT                   /note="Q -> P (in Ref. 2; AAX11356)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        475
FT                   /note="R -> M (in Ref. 3; BAE40273)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        652
FT                   /note="V -> L (in Ref. 4; BAC98102)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        830
FT                   /note="A -> T (in Ref. 3; BAE40273)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1036 AA;  117372 MW;  D397879609881BF1 CRC64;
     MWRFSGRRGL CAVQRLSCGR VHHRVWREKS DQACERALQY KVGEKIHGFT VNQVTPVPEL
     FLTAVKLSHD NTGARYLHLA REDKNNLFSV QFRTTPMDST GVPHVLEHTV LCGSQKYPCR
     DPFFKMLNRS LSTFMNAMTA SDYTIYPFST QNPKDFQNLL SVYLDATFFP CLRELDFWQE
     GWRLEHENPR DPQTPLIFKG VVFNEMKGAF TDNERIFSQH LQNKLLPDHT YSVVSGGDPL
     CIPELTWEQL KQFHATHYHP SNARFFTYGN FQLEGHLKQI HEEALSKFQR LEQSTAVPAQ
     PHWDKPREFH ITCGPDSLAT ETAKQTTVSV SFLLPDITDT FEAFTLSLLS SLLIAGPNSP
     FYKALIESGL GTDFSPDVGY NGYTREAYFS VGLQGIAEKD VKTVRELVDR TIEEVIEKGF
     EDDRIEALLH KIEIQTKHQS ASFGLTLTSY IASCWNHDGD PVELLQIGSQ LTRFRKCLKE
     NPKFLQEKVE QYFKNNQHKL TLSMKPDDKY YEKQTQMETE KLEQKVNSLS PADKQQIYEK
     GLELQTQQSK HQDASCLPAL KVSDIEPSMP FTKLDIGLAA GDIPVQYCPQ PTNGMVYFRA
     FSSLNTLPED LRPIVPLFCS VLTKLGCGIL NYREQAQQIE LKTGGMSVTP HVLPDDSQLD
     TYEQGVLFSS LCLERNLPDM MHLWSEIFNN PCFEEEEHFK VLVKMTAQEL SNGISDSGHL
     YAALRASKTL TPSGDLQETF SGMDQVKVMK RIAEMTDIKP ILRKLPRIKK YLLNCDNMRC
     SVNATPQQMP QAEKEVENFL RNVGRSKKER KPVRPHIVEK PTPSGPSGAA HVSGSQIVRK
     LVTDPTFKPC QMKTHFVLPF PVNYIGECVR TVPYADPDHA SLKILARLMT AKFLHTEIRE
     KGGAYGGGAK LTHSGIFTLY SYRDPNSIET LQSFGKAVDW AKSGKFTQQD IDEAKLSVFS
     TVDSPVAPSD KGMDHFLYGL SDEMKQAYRE QLFAVNHDKL TSVSHKYLGI GKSTHGLAIL
     GPENSKIAKD PSWIIK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024